Dr. Sybil Swift, Science & regulatory affairs Committee

Sibyl Swift, Ph.D. is the Vice President for Scientific & Regulatory Affairs for cbdMD and the co-chair of cbdMD Therapeutics. As VP for cbdMD, she directs the company’s research partnerships, clinical trials, advises on regulatory matters, and provides guidance on good manufacturing practices. Prior to joining cbdMD, Dr. Swift was the Senior Vice President for Scientific & Regulatory Affairs at the Natural Products Association (NPA). In that role, Dr. Swift was responsible for the development and implementation of the association’s education, regulatory, and compliance programs and effort, such as the Supplement Safety and Compliance
Initiative (SSCI), the NPA Natural Standard, and others. She represented the association on Codex Alimentarius (an international standards organization) and provided guidance on claims reviews, substantiation, and regulatory policy. 

 

Before joining NPA, Dr. Swift was the Associate Director for Research and Strategy within the U.S. Food and Drug Administration’s (FDA) Office of Dietary Supplement Programs. As Associate Director, Dr. Swift directed the office’s research portfolio and was responsible for ensuring alignment between its science, research, compliance, enforcement, and policy initiatives. Dr. Swift was also the co-chair of the Botanical Safety Consortium, a collaboration between scientists from government agencies, academia, and industry. 

 

Dr. Swift earned her Ph.D. in nutrition and M.S. in physiology at Texas A&M University. She is currently a member of the American Society for Nutrition.